A Phase 1/2 Clinical Trial of an Alphavirus Replicon Vaccine for Influenza
Clinical trial NCT00440362 · COMPLETED
Trial details
- NCT number
- NCT00440362
- Sponsor
- AlphaVax, Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-04-01
- Primary completion
- 2007-09-01
- Enrollment
- 216
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.